Search
Advanced Search
Metrics info
Average Rating (0 User Ratings)
    • Currently 0/5 Stars.
    Rate This Article
Share this Article info
  • Bookmark: StumbleUpon Facebook Connotea CiteULike Bibliography

Open Access

Policy Forum info

XDR-TB in South Africa: No Time for Denial or Complacency

0 responses
Knowledge for XDR Tuberculosis Control Today Posted by plosmedicine on 31 Mar 2009 at 00:30 GMT
Most recent response on 31 Mar 2009 at 00:30 GMT
0 responses
An Alternate Model of Care of Multiple and Extensively Drug-Resistant Tuberculosis (MDR and XDR TB) Posted by plosmedicine on 31 Mar 2009 at 00:11 GMT
Most recent response on 31 Mar 2009 at 00:11 GMT
0 responses
The Siracusa principles: a blanket approval? Posted by plosmedicine on 31 Mar 2009 at 00:09 GMT
Most recent response on 31 Mar 2009 at 00:09 GMT
0 responses
Tackling drug-resistant TB in South Africa: detention is not the priority Posted by plosmedicine on 31 Mar 2009 at 00:05 GMT
Most recent response on 31 Mar 2009 at 00:05 GMT
0 responses
XDR-TB in South Africa: Theory and Practice Posted by plosmedicine on 31 Mar 2009 at 00:04 GMT
Most recent response on 31 Mar 2009 at 00:04 GMT
0 responses
Revised definition of XDR TB Posted by plosmedicine on 31 Mar 2009 at 00:04 GMT
Most recent response on 31 Mar 2009 at 00:04 GMT
0 responses
Back To TB Sanatoria Perhaps? Posted by plosmedicine on 31 Mar 2009 at 00:04 GMT
Most recent response on 31 Mar 2009 at 00:04 GMT
0 responses
What about infection prevention? Posted by plosmedicine on 31 Mar 2009 at 00:04 GMT
Most recent response on 31 Mar 2009 at 00:04 GMT
Rate This Article
Please follow our guidelines for rating and review our competing interests policy. Comments that do not conform to our guidelines will be promptly removed and the user account disabled. The following must be avoided:
  1. Remarks that could be interpreted as allegations of misconduct
  2. Unsupported assertions or statements
  3. Inflammatory or insulting language
Compose Your Annotation
 
Declare any competing interests.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution License.